Congenital plasminogen activator inhibitor deficiency type 1 (disorder) | | Congenital plasminogen activator inhibitor deficiency type 1 | | Congenital plasminogen activator inhibitor type 1 (PAI-1) deficiency is a rare genetic bleeding disorder characterized by premature lysis of hemostatic clots and a moderate bleeding tendency. Both partial and total PAI-1 deficiencies are extremely rare disorders. PAI-1 is the physiological inhibitor of tissue-type plasminogen activator (t-PA), the main source of intravascular fibrinolysis. Affected patients carry one (heterozygote) or two (homozygote) alleles with a mutation in the SERPINE1 gene (7q22.1), resulting in partial or total antigenic PAI-1 deficiency. Transmitted as autosomal recessive traits. | | congenitale plasminogeenactivator-inhibitor type 1-deficiƫntie | | aangeboren PAI-1-deficiƫntie
|
| Id | 717407006 | Status | Primitive |
DHD Diagnosis thesaurus reference set |
ICD-10 complex map reference set | Target | D68.8 | Rule | TRUE | Advice | ALWAYS D68.8 | Correlation | SNOMED CT source code to target map code correlation not specified |
|
|